An interventional study of Longitudinal incision and Transverse incision in Functional Disturbance as Result, sponsored by Corporacion Parc Tauli. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-10-21.
Sponsored by Corporacion Parc Tauli · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Trigger finger is a common pathology in the hand. Patients suffer from pain and depending on which tasks, patients have difficulty to perform them. Its treatment in initial and less serious phases includes conservative measures, but failure of these may require releasing the trigger finger with surgery. The surgical technique performed for trigger finger is the opening of the A1 pulley, the skin incisions used for this surgery are various (transverse, longitudinal, oblique). Trigger finger surgery presents good results in terms of resolution, but complications may also occur. The reason for this study is to assess whether there are functional differences using the Dash scale when we perform a transverse or longitudinal incision in trigger finger surgery.
Corporacion Parc Tauli is the lead sponsor of 167 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Grade I (pre-trigger) Pain, history of entrapment, but not demonstrable on physical examination, tenderness over the A1 pulley.
Grade II (active) Demonstrable entrapment, but the patient can actively extend the finger.
Grade III (passive) Demonstrable entrapment, patient requires passive extension IIIA or inability to actively flex IIIB.
Grade IV (contracture) Demonstrable entrapment with fixed flexion contracture of the PIP.
Exclusion Criteria:
Incision performed longitudinally
Procedure: Longitudinal incision
Incision performed transversally
Procedure: Transverse incision
Incision performed longitudinally
Incision performed transversally
Functional improvement of the patient after surgery
functional improvement of the patient after surgery, which will be assessed with the Dash scale, 1 being difficult while 5 being unable
Time frame: Immediately after surgery
Surgeon comfort
Ecellent, good, poor
Time frame: Immediately after surgery
Resolution
Presence or absence of engagment
Time frame: 1, 3 and 6 months
Flushed
Red or not red
Time frame: 1, 3 and 6 months
Pain feeling
EVA scale from 0 to 10, being 10 a lot of pain
Time frame: 1, 3 and 6 months
Contracture
Range of motion in degrees
Time frame: 1, 3 and 6 months
Infection
Septic signs such the area is red, hot, swelling or has drain pus
Time frame: 1, 3 and 6 months
Nerve injury
Allen test to evaluate correct circulation, the hand should turn white when pressing
Time frame: 1, 3 and 6 months
Return to work
How many weeks after surgery
Time frame: 1, 3 and 6 months
Reincorporation to activities
How many weeks after surgery
Time frame: 1, 3 and 6 months
Sensitivity Test
In a scale from 0 to 10
Time frame: 1, 3 and 6 months
Plan to share: No
Started May 2024 (actual). Primary completion is estimated for Oct 2027, 41 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: primary completion Feb 2025 → Oct 2027 and completion Mar 2025 → Mar 2028.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.